Learn more about Peter Attia’s digital program
#97 – Peter Hotez, M.D., Ph.D.: COVID-19: transmissibility, vaccines, risk reduction, and treatment
“The next two weeks will be the critical period where we may start to see this reach a peak.” —Peter Hotez, M.D., Ph.D.
Alzheimer’s disease and glucose metabolism
“In Alzheimer’s Research, Glucose Metabolism Moves to Center Stage.”
Qualy #106 – Does LDL cause heart disease?
Today’s episode of The Qualys is from podcast #03 – Ron Krauss, M.D.: a deep dive into heart disease.
#91 – Eric Topol, M.D.: Can AI empower physicians and revolutionize patient care?
“If we lean on machines more. . .we can free up time with patients and we could get the doctor-patient relationship back to where it ought to be.” —Eric Topol, M.D.
#87 – Rick Johnson, M.D.: Metabolic Effects of Fructose
“Fructose turns out to be used by animals as a mechanism to store fat.” — Rick Johnson
Qualy #82 – What is the most common first presentation of heart disease?
Today’s episode of The Qualys is from podcast #03 – Ron Krauss, M.D.: a deep dive into heart disease.
#85 – Iñigo San Millán, Ph.D.: Zone 2 Training and Metabolic Health
“What I have been seeing for 25 years, working with elite athletes, is that [zone 2] is the exercise intensity where I see the biggest improvement in fat burning and the biggest improvement in lactic clearance capacity. Therefore, that means that the mitochondria is where you see the biggest improvement.” —Iñigo San Millán, Ph.D.
Measuring cardiovascular disease risk and the importance of apoB
Millions of Americans schedule an annual physical health examination. During their visit, many can expect to get their blood drawn for…
Coronary artery calcium scan
After last week’s deep dive into the relationship between LDL cholesterol, systolic blood pressure, and cardiovascular disease, I thought it…
Qualy #61 – Rapamycin in cancer treatment
Today’s episode of The Qualys is from podcast #10 – Matt Kaeberlein, Ph.D.: rapamycin and dogs — man’s best friends?…